Jefferies Group’s Salix Pharmaceuticals SLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXP
Jefferies Group's SLXP Position: Q2 2015 in Review
Jefferies Group sold out of Salix Pharmaceuticals (SLXP) in Q2 2015, closing a stake of 7,043 shares — an estimated $1.22M sold.
Jefferies Group first reported a position in SLXP in Q2 2013 and held it in 6 quarters. The position peaked at $4.9M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.
- Jefferies Group reported no remaining Salix Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
- Jefferies Group sold 7,043 Salix Pharmaceuticals shares in Q2 2015, an estimated $1.22M.
- Jefferies Group first reported a position in Salix Pharmaceuticals in Q2 2013 and held it in 6 quarters.
- Jefferies Group's Salix Pharmaceuticals position peaked at $4.9M in Q4 2014.
- 1 fund tracked by Wall St. Rank held Salix Pharmaceuticals as of Q2 2015.
Based on Jefferies Group's 13F filing for Q2 2015, filed 18 Aug 2015.